Join us at the Finance and Accounting for Bioscience Companies Conference!

Designed specifically for bioscience companies, this CPE-accredited annual forum gathers the nation's top financial and accounting professionals from leading innovators. Agenda topics include business scaling strategies, value creation, emerging risks, and digital transformation.

HEAD TO OUR PANEL DISCUSSION ON DAY 1

September 24, 2026 |  8:30 AM - 9:30 AM ET 

Controllership Panel: Driving Operational Excellence in a Transforming Landscape

• Explore how to operationalize recent regulatory changes, including practical strategies for adapting to the FASB’s disaggregation standard (DISE), potential impacts on financial reporting and compliance with evolving audit and reporting requirements

• Gain insights into leveraging AI tools and ERP systems to streamline processes, enhance accuracy and prepare for commercialization

• Hear lessons learned from transitioning from clinical to commercial operations, including inventory management, government pricing and supply chain complexities

• Discuss approaches to talent development, workload management and fostering adaptability in lean finance teams

CPE Credits Available: 1.2

Jen Cadigan

Partner, Accounting Advisory, Life Sciences Lead at CrossCountry Consulting

Additional panelists include:

• Sean Godbout, Chief Accounting Officer, Corporate Controller at Biogen 

• Scott Godsoe, Executive Director, Assistant Corporate Controller at Vertex Pharmaceuticals 

• Richard Malabre, Senior Vice President & Chief Accounting Officer at Akebia Therapeutics 

• Jenni Humes, Chief Accounting Officer at Roivant